Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,236,431
  • Shares Outstanding, K 66,799
  • Annual Sales, $ 4,740 K
  • Annual Income, $ -163,920 K
  • 60-Month Beta 0.55
  • Price/Sales 468.59
  • Price/Cash Flow N/A
  • Price/Book 3.34
Trade CRNX with:

Options Overview Details

View History
  • Implied Volatility 73.27% ( +0.11%)
  • Historical Volatility 42.19%
  • IV Percentile 30%
  • IV Rank 10.35%
  • IV High 258.85% on 09/06/23
  • IV Low 51.86% on 09/29/23
  • Put/Call Vol Ratio 2.77
  • Today's Volume 49
  • Volume Avg (30-Day) 641
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 17,474
  • Open Int (30-Day) 13,290

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.90
  • Number of Estimates 6
  • High Estimate -0.81
  • Low Estimate -1.00
  • Prior Year -0.84
  • Growth Rate Est. (year over year) -7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.75 +29.20%
on 11/10/23
34.09 -2.41%
on 12/06/23
+4.82 (+16.94%)
since 11/08/23
3-Month
24.75 +34.42%
on 09/11/23
34.09 -2.41%
on 12/06/23
+17.30 (+108.33%)
since 09/08/23
52-Week
15.23 +118.45%
on 03/28/23
34.09 -2.41%
on 12/06/23
+15.68 (+89.14%)
since 12/08/22

Most Recent Stories

More News
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 1.4000 (unch)
ONC.TO : 1.90 (-0.52%)
GNLX : 12.84 (+6.56%)
CRNX : 33.27 (-0.63%)
PFE : 28.78 (+0.52%)
SGEN : 218.98 (+0.30%)
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope

USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...

ONCY : 1.4000 (unch)
ONC.TO : 1.90 (-0.52%)
GNLX : 12.84 (+6.56%)
CRNX : 33.27 (-0.63%)
PFE : 28.78 (+0.52%)
SGEN : 218.98 (+0.30%)
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?

Despite good results in phase 3 trials, there are barriers to its drug candidate's success.

CRNX : 33.27 (-0.63%)
Why Crinetics Pharmaceuticals Stock Soared This Week

A positive late-stage trial readout fueled a major rally in the drugmaker's shares.

CRNX : 33.27 (-0.63%)
Stocks Settle Higher as Tesla’s Surge Powers Gains in Tech Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.19%....

$SPX : 4,604.37 (+0.41%)
SPY : 460.20 (+0.43%)
$DOWI : 36,247.87 (+0.36%)
DIA : 363.12 (+0.36%)
$IUXX : 16,084.69 (+0.39%)
QQQ : 392.17 (+0.45%)
TSLA : 243.84 (+0.49%)
CVS : 75.10 (+1.47%)
QCOM : 132.97 (+0.02%)
MTB : 132.65 (-0.10%)
KVUE : 20.61 (-0.96%)
DXCM : 116.97 (-1.61%)
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday

The biotech company reported positive phase 3 trial results.

CRNX : 33.27 (-0.63%)
Stocks Climb on Strength in Tech Stocks and Favorable Chinese News

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stock...

$SPX : 4,604.37 (+0.41%)
SPY : 460.20 (+0.43%)
$DOWI : 36,247.87 (+0.36%)
DIA : 363.12 (+0.36%)
$IUXX : 16,084.69 (+0.39%)
QQQ : 392.17 (+0.45%)
TSLA : 243.84 (+0.49%)
DIS : 92.82 (+0.51%)
CHTR : 367.55 (-0.30%)
STT : 73.97 (+1.08%)
KVUE : 20.61 (-0.96%)
QCOM : 132.97 (+0.02%)
Markets Today: Stock Index Futures Climb on Strength in Tech Stocks and Positive China News

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.47%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.74%. Stock index futures this morning are moderately higher on...

ESZ23 : 4,607.50s (+0.39%)
NQZ23 : 16,098.25s (+0.37%)
TSLA : 243.84 (+0.49%)
QCOM : 132.97 (+0.02%)
MSFT : 374.23 (+0.88%)
TWNK : 33.30 (-0.15%)
SQ : 69.17 (+1.02%)
CRNX : 33.27 (-0.63%)
KVUE : 20.61 (-0.96%)
TENB : 41.15 (+0.83%)
RTX : 81.32 (-0.22%)
OVV : 41.63 (+0.99%)
Stocks Set to Open Higher as Investors Await U.S. Inflation Data, Yellen Comments Boost Sentiment

September S&P 500 futures (ESU23) are up +0.42%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.55% this morning as remarks from Treasury Secretary Janet Yellen bolstered hopes that the U.S....

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
SWBI : 12.61 (-9.08%)
KR : 44.58 (-0.49%)
BA : 244.70 (+3.11%)
1COV.D.DX : 51.200 (-0.19%)
TSLA : 243.84 (+0.49%)
CRNX : 33.27 (-0.63%)
TWNK : 33.30 (-0.15%)
DASH : 100.00 (+1.04%)
KVUE : 20.61 (-0.96%)
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) delivered earnings and revenue surprises of -3.66% and 325.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CRNX : 33.27 (-0.63%)
RVMD : 24.59 (+0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly,...

See More

Key Turning Points

3rd Resistance Point 34.45
2nd Resistance Point 34.00
1st Resistance Point 33.64
Last Price 33.27
1st Support Level 32.83
2nd Support Level 32.38
3rd Support Level 32.02

See More

52-Week High 34.09
Last Price 33.27
Fibonacci 61.8% 26.89
Fibonacci 50% 24.66
Fibonacci 38.2% 22.43
52-Week Low 15.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar